| Original language | English (US) |
|---|---|
| Pages (from-to) | 2395-2398 |
| Number of pages | 4 |
| Journal | Leukemia |
| Volume | 28 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 11 2014 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression. / Ojha, J.; Secreto, C.; Rabe, K.; Ayres-Silva, J.; Tschumper, R.; Dyke, D. V.; Slager, S.; Fonseca, R.; Shanafelt, T.; Kay, N.; Braggio, E.
In: Leukemia, Vol. 28, No. 12, 11.12.2014, p. 2395-2398.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity many years before disease progression
AU - Ojha, J.
AU - Secreto, C.
AU - Rabe, K.
AU - Ayres-Silva, J.
AU - Tschumper, R.
AU - Dyke, D. V.
AU - Slager, S.
AU - Fonseca, R.
AU - Shanafelt, T.
AU - Kay, N.
AU - Braggio, E.
N1 - Funding Information: RF has received a patent for the prognostication of MM based on genetic categorization of the disease. He has received consulting fees from Medtronic, Otsuka, Celgene, Genzyme, BMS, Lilly, Onyx, Binding Site, Millenium and AMGEN. He also has sponsored research from Cylene and Onyx. TS was supported by fundings from Hospira, Genentech, Glaxo-Smith-Kline, Jannsen, Celgene and Cephalon. The remaining authors declare no conflcit of interest. Funding Information: EB is a recipient of the Marriott Specialized Workforce Development Awards in Individualized Medicine and the Henry Predolin Foundation Career Development Award. This work was supported by the Henry Predolin Foundation and grant NIH-CA95241.
PY - 2014/12/11
Y1 - 2014/12/11
UR - http://www.scopus.com/inward/record.url?scp=84926984290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84926984290&partnerID=8YFLogxK
U2 - 10.1038/leu.2014.226
DO - 10.1038/leu.2014.226
M3 - Letter
C2 - 25034147
AN - SCOPUS:84926984290
VL - 28
SP - 2395
EP - 2398
JO - Leukemia
JF - Leukemia
SN - 0887-6924
IS - 12
ER -